In the last 12 months, insiders at Grace Therapeutics, Inc. ($GRCE) filed 20 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Grace Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- D'Andrea Carrie (VP Program Management) — 1 transaction totaling $0
- NEUGEBOREN EDWARD (Not found) — 2 transactions totaling $0
- D'Andrea Carrie (VP Clinical Operations) — 2 transactions totaling $0
- DelAversano Robert J (Principal Financial Officer) — 2 transactions totaling $0
- DAVIS A BRIAN (Not found) — 2 transactions totaling $0
View all SEC Filings for Grace Therapeutics, Inc. (GRCE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2026 | Kottayil George | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 16,933,620 | 9999.99% | 0.06% |
| Jan. 8, 2026 | NEUGEBOREN EDWARD | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 16,933,620 | 9999.99% | 0.06% |
| Jan. 8, 2026 | DAVIS A BRIAN | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 16,933,620 | 9999.99% | 0.06% |
| Jan. 8, 2026 | Kavuru Vimal | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 16,933,620 | 9999.99% | 0.06% |
| May 9, 2025 | Kottayil George | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 12,087,270 | 9999.99% | 0.08% |
| May 9, 2025 | NEUGEBOREN EDWARD | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 12,087,270 | 9999.99% | 0.08% |
| May 9, 2025 | DAVIS A BRIAN | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 12,087,270 | 9999.99% | 0.08% |
| May 9, 2025 | Kavuru Vimal | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 12,087,270 | 9999.99% | 0.08% |
| April 14, 2025 | Kumar Amresh | VP Program Management | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 12,087,270 | 9999.99% | 0.25% |
| April 14, 2025 | DelAversano Robert J | Principal Financial Officer | A | Stock Option (Right to Buy) | 20130 | $0.00 | 20,130.0000 | 12,087,270 | 9999.99% | 0.17% |
| April 14, 2025 | Kohli Prashant | Chief Executive Officer | A | Stock Option (Right to Buy) | 225400 | $0.00 | 225,400.0000 | 12,087,270 | 9999.99% | 1.86% |
| April 14, 2025 | D'Andrea Carrie | VP Clinical Operations | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 12,087,270 | 9999.99% | 0.25% |
| April 14, 2025 | Macdonald R. Loch | Chief Medical Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 12,087,270 | 9999.99% | 0.33% |
| May 6, 2024 | D'Andrea Carrie | VP Clinical Operations | A | Stock Options (Right to Buy) | 19740 | $0.00 | 19,740.0000 | 9,529,123 | 9999.99% | 0.21% |
| May 6, 2024 | Kumar Amresh | VP Program Management | A | Stock Options (Right to Buy) | 19740 | $0.00 | 19,740.0000 | 9,529,123 | 9999.99% | 0.21% |
| May 6, 2024 | Kumar Amresh | VP Clinical Operations | A | Stock Options (Right to Buy) | 19740 | $0.00 | 19,740.0000 | 9,529,123 | 9999.99% | 0.21% |
| May 6, 2024 | Macdonald R. Loch | Chief Medical Officer | A | Stock Options (Right to Buy) | 25380 | $0.00 | 25,380.0000 | 9,529,123 | 9999.99% | 0.27% |
| May 6, 2024 | DelAversano Robert J | Principal Financial Officer | A | Stock Options (Right to Buy) | 4500 | $0.00 | 4,500.0000 | 9,529,123 | 9999.99% | 0.05% |
| May 6, 2024 | Kohli Prashant | Chief Executive Officer | A | Stock Options (Right to Buy) | 128770 | $0.00 | 128,770.0000 | 9,529,123 | 9999.99% | 1.35% |
| May 6, 2024 | D'Andrea Carrie | VP Program Management | A | Stock Options (Right to Buy) | 19740 | $0.00 | 19,740.0000 | 9,529,123 | 9999.99% | 0.21% |